chemical

Talampanel

T-185

T-185_10 mg

Talampanel

Non Antibodies

S. Molecules

Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C

Glutamate is the main excitatory neurotransmitter in the CNS and is also involved in a variety of pathological conditions including epilepsy. Glutamate binds to a number of different receptors such as AMPA, Kainate and NMDA that relay its excitatory activity.Talampanel (Ampanel, Kinampa, LY 300164, GYKI 53773) is a potent non-competitive AMPA and Kainate antagonist. It has an effective concentration of 10-300 µM. Talampanel was examined in several animal models; sub protective doses of Talampanel potentiate the anticonvulsant effect of other anticonvulsant drugs such as valproate and phenytoin. In addition, it shows neuroprotective properties by enabling the survival of hippocampal neurons after carotid artery occlusion. Repeated administrations of Talampanel in rats undergoing middle cerebral artery occlusion (MCAO) caused an improvement in rotarod and beam walking and reduced the number of MCAO induced rotations compared to rats receiving placebo treatment. In humans, Talampanel is administered orally and is well absorbed. It reaches peak concentration after 2 hours with a half-life of 4 hours. In humans, administering valproate with talampanel does not affect talampanel and N-acetyl-talampanel kinetics. Talampanel is used for the treatment of epilepsy and is well tolerated in adults with refractory complex partial seizures. Its main adverse effects are dizziness and ataxia.

Alomone Labs

AMPA/Kainate receptors

Talampanel (#T-185) is a highly pure, synthetic, and biologically active compound.

A Potent Non-Competitive Antagonist of AMPA/Kainate Receptors

337.37

Ampanel, Kinampa, LY 300164, GYKI 53773

Synthetic

C19H19N3O3.

10-300 µM.

Talampanel is a potent non-competitive AMPA/kainate receptor antagonist. It potentiates the anticonvulsive activity of antiepileptic drugs in animal models of seizures and is orally active1.

100 mM in DMSO. Centrifuge all product preparations before use (10,000 x g for 1 min).

100 mM in DMSO. Centrifuge all product preparations before use (10,000 x g for 1 min).

Up to four weeks at 4°C or three months at -20°C.

1-2 Business Days

Israel/IL

Application key: FC- Flow cytometry, IFC- Indirect flow cytometry, IHC- Immunohistochemistry,LCI- Live cell imaging, Calcium imaging assay,Cell survival assay, Electrophysiology, Neurite outgrowth assay.

>97.8%

161832-65-1

Lyophilized powder.

Contact Alomone Labs for technical support and product customization

41116134

Yes

1-[(8R)-5-(4-aminophenyl)-8-methyl-8,9-dihydro-[1,3]dioxolo[4,5-h][2,3]benzodiazepin-7-yl]ethanone.